Literature DB >> 9191188

Recombinant RFB4 single-chain immunotoxin that is cytotoxic towards CD22-positive cells.

E Mansfield1, M F Chiron, P Amlot, I Pastan, D J FitzGerald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9191188     DOI： 10.1042/bst0250709

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   4.919


× No keyword cloud information.
  11 in total

Review 1.  Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Clin Cancer Res       Date:  2011-10-15       Impact factor: 12.531

Review 2.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

Review 3.  Hairy cell leukemia: present and future directions.

Authors:  Robert J Kreitman
Journal:  Leuk Lymphoma       Date:  2019-05-09

4.  Production of unique immunotoxin cancer therapeutics in algal chloroplasts.

Authors:  Miller Tran; Christina Van; Daniel J Barrera; Pär L Pettersson; Carlos D Peinado; Jack Bui; Stephen P Mayfield
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

Review 5.  Immunoconjugates in the management of hairy cell leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-09       Impact factor: 3.020

Review 6.  Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.

Authors:  Robert J Kreitman
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

7.  Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Oncologist       Date:  2019-10-18

8.  A recombinant immunotoxin targeting CD22 with low immunogenicity, low nonspecific toxicity, and high antitumor activity in mice.

Authors:  Johanna K Hansen; John E Weldon; Laiman Xiang; Richard Beers; Masanori Onda; Ira Pastan
Journal:  J Immunother       Date:  2010-04       Impact factor: 4.912

Review 9.  Clinical targeting recombinant immunotoxins for cancer therapy.

Authors:  Meng Li; Zeng-Shan Liu; Xi-Lin Liu; Qi Hui; Shi-Ying Lu; Lin-Lin Qu; Yan-Song Li; Yu Zhou; Hong-Lin Ren; Pan Hu
Journal:  Onco Targets Ther       Date:  2017-07-20       Impact factor: 4.147

Review 10.  Development of Recombinant Immunotoxins for Hairy Cell Leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Biomolecules       Date:  2020-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.